Dissect formative pluripotency using cultured pluripotent stem cells
使用培养的多能干细胞剖析形成性多能性
基本信息
- 批准号:10297495
- 负责人:
- 金额:$ 34.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-22 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffinity ChromatographyCell Differentiation processCell LineageCellsChIP-seqCharacteristicsChemicalsChimera organismClustered Regularly Interspaced Short Palindromic RepeatsCompetenceDerivation procedureDevelopmentDevelopmental BiologyEmbryoEpiblastFibroblast Growth FactorFibroblast Growth Factor ReceptorsFoundationsGastrulaGene Expression ProfileGenerationsGeneticGerm CellsGoalsHomeodomain ProteinsHumanIn SituIn VitroInfertilityLaboratoriesMaintenanceMethodsModelingMolecularMusNamesOocytesOogoniaPathway interactionsPhasePhenotypePlayPluripotent Stem CellsProteinsProteomicsRegenerative MedicineRegulationRegulatory ElementReproductive BiologyResourcesRoleSignal TransductionSomatic CellStructure of primordial sex cellStudy modelsTestingTimeTissuesTransforming Growth Factor betaTransgenesValidationaustinbaseblastocystcell typeembryonic stem cellestablished cell lineexperimental studyimplantationin vivoinduced pluripotent stem cellinsightnovelpermissivenesspluripotencyregeneration potentialstem cell modelstem cellstooltranscription factortranscriptome
项目摘要
PROJECT SUMMARY/ABSTRACT
Derivation of pluripotent stem cells (PSCs) has revolutionized developmental biology and regenerative
medicine. To stably maintain PSCs in culture and guide them to differentiate with high efficiency and fidelity into
a variety of cell types, it is important to understand the molecular mechanisms governing pluripotency (the ability
of a cell to generate any tissues in the body). Two phases of pluripotency, naïve and primed, have been defined
and studied in detail thanks to the successful derivation of mouse embryonic stem cells (ESCs) and epiblast
stem cells (EpiSCs), respectively. Mouse ESCs most closely resemble epiblast from a 4-day-old mouse
blastocyst (~embryonic day 4, or E4), while “primed” EpiSCs display a global gene expression signature similar
to the E7 epiblast of a post-implantation mouse embryo. Despite these advances, however, however, there is
lack of a well-established PSC model that resembles E5-6 early post-implantation epiblast, which corresponds
to the formative phase of pluripotency. Formative pluripotency exists within a time window during which naïve
pluripotency is reconfigured to prepare for multilineage competency, including germ cells. Functionally, formative
pluripotency is characterized by both chimera competency and permissiveness for direct primordial germ cell
(PGC) induction. Several recent studies have attempted to define this state by transient epiblast-like cells
(EpiLCs) differentiated from ESCs. To date, however, stable formative PSCs have not yet been generated. By
modulating the FGF, TGF-β and WNT pathways, we recently derived PSCs from both mice and humans (referred
to as FTW-PSCs) that are permissive for direct PGC-like cell induction in vitro and are capable of contributing to
intra- or inter-species chimeras in vivo. FTW-PSCs harbor molecular, cellular and phenotypic features
characteristic of formative pluripotency. The overall objective of this proposal is to use these newly
established cell lines to comprehensively dissect the formative state across species. The proposed
studies will elucidate the roles of several transcription factors in regulating mouse and human formative
pluripotency, as well as demonstrate that FTW-PSCs are a robust platform for dissecting the molecular
mechanisms underlying human and mouse PGC specification. In addition, we will establish an in vitro platform
for the generation of functional mouse oocytes and human oogonia based on formative FTW-PSCs, thereby
providing an invaluable resource for studying germ cell development and human infertility. Our proposal has
tremendous potential to revolutionize regenerative medicine and reproductive biology.
项目总结/摘要
多能干细胞(PSC)的衍生已经彻底改变了发育生物学和再生生物学。
药为了稳定地维持PSC在培养物中并引导其高效且保真地分化为
多种细胞类型,重要的是要了解管理多能性的分子机制(能力
细胞生成体内任何组织的能力)。多能性的两个阶段,幼稚和引发,已被定义
并详细研究了由于小鼠胚胎干细胞(ESC)和外胚层的成功衍生,
干细胞(EpiSC)。小鼠胚胎干细胞与4日龄小鼠的上胚层最相似
胚泡(~胚胎第4天,或E4),而“致敏的”EpiSC显示出与胚胎第4天相似的全局基因表达特征。
植入后小鼠胚胎的E7外胚层。尽管有这些进步,但是,
缺乏类似于E5-6早期植入后上胚层的良好建立的PSC模型,其对应于
进入多能性的形成阶段。形成性多能性存在于一个时间窗口内,在此期间,
多能性被重新配置以准备多谱系能力,包括生殖细胞。功能性,形成性
多能性的特征是嵌合体能力和对直接原始生殖细胞的容许性
(PGC)诱导最近的几项研究试图通过短暂的外胚层样细胞来定义这种状态
(EpiLCs)从ESC分化。然而,迄今为止,尚未产生稳定形成的PSC。通过
通过调节FGF、TGF-β和WNT通路,我们最近从小鼠和人获得PSC(参考文献100)。
作为FTW-PSC),其允许体外直接的PGC样细胞诱导,并且能够有助于
种内或种间嵌合体。FTW-PSC具有分子、细胞和表型特征
具有形成性多能性的特征。这项建议的总体目标是利用这些新的
建立了细胞系,以全面剖析不同物种的形成状态。拟议
研究将阐明几种转录因子在调节小鼠和人类形成中的作用,
多能性,以及证明FTW-PSC是一个强大的平台,用于解剖分子
人类和小鼠PGC特化的潜在机制。此外,我们将建立一个体外平台,
用于基于形成性FTW-PSC产生功能性小鼠卵母细胞和人卵原细胞,从而
为研究生殖细胞发育和人类不育提供了宝贵的资源。我们的建议
巨大的潜力来彻底改变再生医学和生殖生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun Wu其他文献
Jun Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jun Wu', 18)}}的其他基金
Dissect the mechanisms underlying interspecies pluripotent stem cell competition
剖析种间多能干细胞竞争的机制
- 批准号:
10576347 - 财政年份:2022
- 资助金额:
$ 34.04万 - 项目类别:
Dissect the mechanisms underlying interspecies pluripotent stem cell competition
剖析种间多能干细胞竞争的机制
- 批准号:
10364140 - 财政年份:2022
- 资助金额:
$ 34.04万 - 项目类别:
Dissect formative pluripotency using cultured pluripotent stem cells
使用培养的多能干细胞剖析形成性多能性
- 批准号:
10455585 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
Dissect formative pluripotency using cultured pluripotent stem cells
使用培养的多能干细胞剖析形成性多能性
- 批准号:
10621933 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
- 批准号:
10371184 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
- 批准号:
10559556 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
- 批准号:
10092344 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
Derivation of chimera competent pig embryonic stem cells under a novel condition
在新条件下衍生嵌合体感受态猪胚胎干细胞
- 批准号:
10205187 - 财政年份:2020
- 资助金额:
$ 34.04万 - 项目类别:
The role of immune-adipocyte cholinergic signaling during metabolic adaptation and dysfunction
免疫脂肪细胞胆碱能信号在代谢适应和功能障碍中的作用
- 批准号:
10570872 - 财政年份:2016
- 资助金额:
$ 34.04万 - 项目类别:
The role of immune-adipocyte cholinergic signaling during metabolic adaptation and dysfunction
免疫脂肪细胞胆碱能信号在代谢适应和功能障碍中的作用
- 批准号:
10202938 - 财政年份:2016
- 资助金额:
$ 34.04万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 34.04万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 34.04万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 34.04万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 34.04万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 34.04万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 34.04万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 34.04万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 34.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 34.04万 - 项目类别:
Collaborative Research and Development Grants